RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MASTRULLO L
Collezione AOU Città della Salute di Torino

Items : 3

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study). in Annals of hematology / Ann Hematol. 2019 Feb;98(2):361-367. doi: 10.1007/s00277-018-3524-1. Epub 2018 Oct 23.

2019
AOU Città della Salute di Torino

Caravita T; Reddiconto G; Fragasso A; Di Renzo N; Genuardi M; Bringhen S; Mansueto G; D'Arena G; Pietrantuono G; Villani O; Gagliardi A; Mastrullo L; Catalano L; Salvatore D; Ria R; Conticello C; Di Raimondo F; Cesini L; Petrucci MT; Falcone A; Cascavilla N; Simeon V; Musto P; Scapicchio D; Marziano G; Boccadoro M; Mangiacavalli S; Corso A; Musto P; et alii...

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma. in Oncotarget / Oncotarget. 2018 May 4;9(34):23443-23450. doi: 10.18632/oncotarget.25215. eCollection 2018 May 4.

2018
AO Cuneo
AOU Città della Salute di Torino

Castellino C; Mastrullo L; Marasca R; Santambrogio E; Vanazzi A; D'Alò F; Rigolin GM; Ilariucci F; Molica S; Cascavilla N; Tosi P; Di Renzo N; Baldini L; Zilioli VR; Paolini R; Visco C; Merli M; Pisani F; Spina F; Ferrero S; Volpetti S; Spina M; Gotti M; Sottotetti F; Morigi A; Casadei B; Broccoli A; Desabbata G; Scortechini I; et alii...

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2016 Jun;60:154-65. doi: 10.1016/j.ejca.2016.03.069. Epub 2016 Apr 27.

2016
AOU Città della Salute di Torino

Gentile M; Zirlik K; Ciolli S; Mauro FR; Di Renzo N; Mastrullo L; Angrilli F; Molica S; Tripepi G; Giordano A; Di Raimondo F; Selleri C; Coscia M; Musso M; Orsucci L; Mannina D; Rago A; Giannotta A; Ferrara F; Herishanu Y; Shvidel L; Tadmor T; Scortechini I; Ilariucci F; Murru R; Guarini A; Musuraca G; Mineo G; Vincelli I; et alii...